- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library
 |
 |
Phospho-tau422 (p-tau422) antibody and antigen (Recombinant protein)
Diagnostic Phospho-tau422 (p-tau422) antibodies (anti-Phospho-tau422, anti-p-tau422) and antigens (recombinant Phospho-tau422 (p-tau422) protein) for Neurodegenerative diseases p-tau422 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to
Neurodegenerative diseases diagnostics
products collection
>>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-h-p-tau422-Ag01 | Anti-human MAPT/p-tau422/MAPTL/MTBT1 mouse monoclonal antibody (mAb) | 1823 |
| GMP-h-p-tau422-Ab01 | Anti-human MAPT/p-tau422/MAPTL/MTBT1 mouse monoclonal antibody (mAb) | 1953 |
| GMP-h-p-tau422-Ab02 | Anti-human MAPT/p-tau422/MAPTL/MTBT1 mouse monoclonal antibody (mAb) | 1953 |
| GMP-h-p-tau422-Ab03 | Anti-human MAPT/p-tau422/MAPTL/MTBT1 human monoclonal antibody (mAb) | 1953 |
| GMP-h-p-tau422-Ab04 | Anti-human MAPT/p-tau422/MAPTL/MTBT1 human monoclonal antibody (mAb) | 1953 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. of Products | GMP-h-p-tau422-Ag01, GMP-h-p-tau422-Ab01, GMP-h-p-tau422-Ab02 |
| Product Name | Anti-human MAPT/p-tau422/MAPTL/MTBT1 mouse monoclonal antibody (mAb) |
| Target/Biomarker | Phospho-tau422 (p-tau422) |
| Alias of Target/Biomarker | DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, PPP1R103, TAU, Tau-PHF6, tau-40 |
| Expression platform | synthesized |
| Isotypes | NA |
| Bioactivity validation | Phospho-tau422 (p-tau422) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in p-tau422 level test of Neurodegenerative diseases (Alzheimer Disease (AD)) and related syndrome evaluation. |
| Products description | Anti-human MAPT/p-tau422/MAPTL/MTBT1 mouse monoclonal antibody (mAb) was expressed in synthesized expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-h-p-tau422-Ab03, GMP-h-p-tau422-Ab04 |
| Product Name | Anti-human MAPT/p-tau422/MAPTL/MTBT1 human monoclonal antibody (mAb) |
| Target/Biomarker | Phospho-tau422 (p-tau422) |
| Alias of Target/Biomarker | DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, PPP1R103, TAU, Tau-PHF6, tau-40 |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Phospho-tau422 (p-tau422) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in p-tau422 level test of Neurodegenerative diseases (Alzheimer Disease (AD)) and related syndrome evaluation. |
| Tag | hFc |
| Products description | Anti-human MAPT/p-tau422/MAPTL/MTBT1 human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Associated products
- Recommend Pair Antibody and Antigen
- Associated products
| Pair Antibody and Antigen | Products detail | Cat.No | Product Name |
| P-tau217 | 1. Antigen | 1. GMP-h-p-tau217-Ag01 | Phospho-tau217 (p-tau217) antigen |
| 2. Capture antibody | 2. GMP-h-p-tau217-Ab01 | Anti-human p-tau217 mouse monoclonal antibody(mAb) | |
| 3. Detector antibody | 3. GMP-h-Tau-Ab03 | Recombinant human Tau Protein | |
| P-tau181 | 1. Antigen | 1. GMP-h-p-tau181-Ag01 | Phospho-tau181 (p-tau181) antigen |
| 2. Capture antibody | 2. GMP-h-p-tau181-Ab01 | Anti-human p-tau181 mouse monoclonal antibody(mAb) | |
| 3. Detector antibody | 3. GMP-h-Tau-Ab03 | Recombinant human Tau Protein | |
| P-tau231 | 1. Antigen | 1. GMP-h-p-tau231-Ag01 | Phospho-tau231 (p-tau231) antigen |
| 2. Capture antibody | 2. GMP-h-p-tau231-Ab01 | Anti-human p-tau231 mouse monoclonal antibody(mAb) | |
| 3. Detector antibody | 3. GMP-h-Tau-Ab03 | Recombinant human Tau Protein |
| Catalog No. | Products Name | Biomarker | Fc/Tag | Products Information |
| GMP-h-p-tau202/205-Ab | Anti-human p-tau202 and 205 monoclonal antibody(mAb) | Phospho-tau202 and 205 (p-tau202 and 205) | hFc/mFc | Details |
| GMP-h-p-tau212/214-Ab | Anti-human p-tau212 and 214 monoclonal antibody(mAb) | Phospho-tau212 and 214 (p-tau212 and 214) | hFc/mFc | Details |
| GMP-h-p-tau413-Ab | Anti-human p-tau413 monoclonal antibody(mAb) | Phospho-tau413 (p-tau413) | hFc/mFc | Details |
| GMP-h-p-tau422-Ab | Anti-human p-tau422 monoclonal antibody(mAb) | Phospho-tau422 (p-tau422) | hFc/mFc | Details |
| GMP-h-Tau-Ab | Anti-human Tau monoclonal antibody(mAb) | tau proteins (Tau) | hFc/mFc | Details |
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
Comments
No comments yet.